[联合avelumab和立体定向消融体放疗治疗转移性去势抵抗性前列腺癌:疗效和安全性II期ICE-PAC]。

{"title":"[联合avelumab和立体定向消融体放疗治疗转移性去势抵抗性前列腺癌:疗效和安全性II期ICE-PAC]。","authors":"Ulrich Alexander Krafft","doi":"10.1007/s00120-021-01743-x","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11123,"journal":{"name":"Der Urologe. Ausg. A","volume":"61 3","pages":"301-303"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Combining avelumab and stereotactic ablative body radiotherapy in metastatic castration-resistant prostate cancer : Efficacy and safety-phase II ICE-PAC].\",\"authors\":\"Ulrich Alexander Krafft\",\"doi\":\"10.1007/s00120-021-01743-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11123,\"journal\":{\"name\":\"Der Urologe. Ausg. A\",\"volume\":\"61 3\",\"pages\":\"301-303\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Der Urologe. Ausg. A\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s00120-021-01743-x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/12/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Der Urologe. Ausg. A","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00120-021-01743-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/12/16 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}